User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Cytokines: clues to the pathogenesis of SLE.

  1. Linker-Israeli Mariana, Cytokine abnormalities in human lupus, 10.1016/0090-1229(92)90084-2
  2. Handwerger Barry S., Rus Violeta, da Silva Ludmila, Via Charles S., The role of cytokines in the immunopathogenesis of lupus, 10.1007/bf00197515
  3. Horwitz DavidA., Jacob ChaimO., The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications, 10.1007/bf00197516
  4. Alcocer-Varela J, Alarcón-Segovia D, Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus., 10.1172/jci110579
  5. Horwitz DA, Clin Exp Immunol, 27, 92 (1997)
  6. Crispin J C, Alcocer-Varela J, Interleukin-2 and systemic lupus erythematosus—fifteen years later, 10.1191/096120398678920028
  7. Murakawa Yohko, Sakane Tsuyoshi, Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate, 10.1002/art.1780310702
  8. GARCIA-COZAR F. J., MOLINA I. J., CUADRADO M. J., MARUBAYASHI M., PENA J., SANTAMARIA M., Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients, 10.1046/j.1365-2249.1996.d01-648.x
  9. Huang YP, J Immunol, 137, 3515 (1986)
  10. Horwitz David A., Hua Wang, Gray J. Dixon, Cytokine Gene Profile in Circulating Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus: Increased Interleukin-2 but not Interleukin-4 mRNA, 10.1177/096120339400300511
  11. Tsokos George C., Kovacs Birgit, Sfikakis Peter P., Theocharis Stamatis, Vogelgesang Scott, Via Charles S., Defective antigen-presenting cell function in patients with systemic lupus erythematosus: Role of the B7-1 (CD80) costimulatory molecule, 10.1002/art.1780390409
  12. Mosman Tim R., Properties and Functions of Interleukin-10, Advances in Immunology Volume 56 (1994) ISBN:9780120224562 p.1-26, 10.1016/s0065-2776(08)60449-6
  13. Llorente L, Eur Cytokine Net, 4, 421 (1993)
  14. Llorente Luis, Richaud-Patin Yvonne, Fior Renato, Alcocer-Varela Jorge, Wijdenes John, Fourrier Brigitte Morel, Galanaud Pierre, Emilie Dominique, In vivo production of interleukin-10 by non–t cells in rheumatoid arthritis, sjöugren's syndrome, and systemic lupus erythematosus., 10.1002/art.1780371114
  15. Houssiau FA, Lefebvre C., Vanden Berghe M., Lambert M., Devogelaer J-P., Renauld J-C., Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity, 10.1177/096120339500400510
  16. Hagiwara Eri, Gourley Mark F., Lee Susie, Klinman Dennis M., Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-γ–secreting cells in the peripheral blood, 10.1002/art.1780390305
  17. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J. C., Alarcon-Segovia D., Galanaud P., Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus, 10.1084/jem.181.3.839
  18. Linker-Israeli M, J Immunol, 147, 117 (1991)
  19. Ishida H., Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice, 10.1084/jem.179.1.305
  20. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G., Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus, 10.1111/j.1399-0039.1997.tb02812.x
  21. Lazarus M, J Rheumatol
  22. Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V., AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN-10 GENE PROMOTER, 10.1111/j.1365-2370.1997.tb00001.x
  23. Llorente Luis, Richaud-Patin Yvonne, Couderc Jacques, Alarcon-Segovia Donato, Ruiz-Soto Rodrigo, Alcocer-Castillejos Natasha, Alcocer-Varela Jorge, Granados Julio, Bahena Susana, Galanaud Pierre, Emilie Dominique, Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus, 10.1002/art.1780400810
  24. Jacob C. O., In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon, 10.1084/jem.166.3.798
  25. Ozmen Laurence, Roman Danièle, Fountoulakis Michael, Schmid Georges, Ryffel Bernhard, Garotta Gianni, Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis, 10.1002/eji.1830250103
  26. Peng S L, Moslehi J, Craft J, Roles of interferon-gamma and interleukin-4 in murine lupus., 10.1172/jci119361
  27. Trinchieri G, Blood, 84, 4008 (1994)
  28. HOUSSIAU F. A., MASCART-LEMONE F., STEVENS M., LIBIN M., DEVOGELAER J.-P., GOLDMAN M., RENAULD J.-C., IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC), 10.1046/j.1365-2249.1997.d01-1009.x
  29. Morris M.M., Piddlesden S., Groome N., Amor S., Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice, 10.1016/s0165-2478(97)86266-9
  30. Hagiwara E, Arthritis Rheum, 40, S257 (1997)
  31. Lauwerys B, Inhibition of in vitro immunoglobulin production by interleukin-12 in murine chronic graft-vs-host disease: synergism with interleukin-18 (submitted for publication)
  32. Ushio S, J Immunol, 156, 4274 (1996)
Bibliographic reference Lauwerys, Bernard ; Houssiau, Frédéric. Cytokines: clues to the pathogenesis of SLE.. In: Lupus, Vol. 7, no. 4, p. 211-3 (1998)
Permanent URL http://hdl.handle.net/2078.1/27551